Skip to main content
Premium Trial:

Request an Annual Quote

Todd Johnson, Pol Bamelis, Jing Zhang

Premium
MDS Pharma Services has appointed Todd Johnson to be senior vice president of strategy and corporate development.
 
Johnson previously was a strategic consultant for pharmaceutical and biotechnology companies at McKinsey & Company. He also was CEO of Tangerine Technologies and was a cancer researcher at Harvard’s Dana-Farber Cancer Institute, the University of Pennsylvania, and at the National Institutes of Health
 

 
Belgian company Devgen has appointed Pol Bamelis to be chairman of the board.
 
Bamelis has been chairman of the Agfa group and a director at Bayer and the University of Leuven.
 

 
Jing Zhang has been awarded the 2007 Alzheimer’s Award by the Journal of Alzheimer’s Disease. The journal gave Zhang the award for the paper “Detection of Biomarkers with a Multiplex Quantitative Proteomic Platform in Cerebrospinal Fluid of Patients with Neurodegenerative Disorders,” which resulted from a study Zhang led that included a number of other researchers.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.